222 related articles for article (PubMed ID: 11201890)
1. Experience and lessons from the use of lepromin and Mycobacterium leprae-specific serology.
Sengupta U
Lepr Rev; 2000 Dec; 71 Suppl():S63-6. PubMed ID: 11201890
[TBL] [Abstract][Full Text] [Related]
2. IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS.
SHEPARD CC; GUINTO RS
J Exp Med; 1963 Aug; 118(2):195-204. PubMed ID: 14074384
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
[TBL] [Abstract][Full Text] [Related]
4. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
[TBL] [Abstract][Full Text] [Related]
5. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
6. Studies on lepromin and soluble antigens of M.leprae: their classification standardization and use.
Sengupta U
Indian J Lepr; 1991; 63(3-4):457-65. PubMed ID: 1804898
[TBL] [Abstract][Full Text] [Related]
7. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
8. Skin test development in leprosy: progress with first-generation skin test antigens, and an approach to the second generation.
Brennan PJ
Lepr Rev; 2000 Dec; 71 Suppl():S50-4. PubMed ID: 11201887
[TBL] [Abstract][Full Text] [Related]
9. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
[TBL] [Abstract][Full Text] [Related]
10. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
[TBL] [Abstract][Full Text] [Related]
11. Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size.
Goulart IM; Cardoso AM; Santos MS; Gonçalves MA; Pereira JE; Goulart LR
Arch Dermatol Res; 2007 Aug; 299(5-6):267-71. PubMed ID: 17530267
[TBL] [Abstract][Full Text] [Related]
12. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
[TBL] [Abstract][Full Text] [Related]
14. Sub-clinical infection with Mycobacterium leprae in household contacts of leprosy.
Bhatia VN; Dhandayuthapani S; Ananthan D; Rajendran M; Vasanth B; Jayasingh K; Kumar CH
Indian J Lepr; 1990; 62(3):296-304. PubMed ID: 2262713
[TBL] [Abstract][Full Text] [Related]
15. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
Parkash O; Girdhar BK
Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
[TBL] [Abstract][Full Text] [Related]
16. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
18. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
David HL; Maroja M F; Cruaud P
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
[No Abstract] [Full Text] [Related]
19. Leprosy in children: correlation of clinical, histopathological, bacteriological and immunological parameters.
Sehgal VN; Joginder
Lepr Rev; 1989 Sep; 60(3):202-5. PubMed ID: 2682106
[TBL] [Abstract][Full Text] [Related]
20. T lymphocyte reactivity of leprosy patients and healthy contacts from a leprosy-endemic population to delipidified cell components of Mycobacterium leprae.
Ilangumaran S; Robinson P; Shankernarayan NP; Ramu G; Mahadevan PR; Muthukkaruppan VR
Lepr Rev; 1994 Mar; 65(1):34-44. PubMed ID: 8201834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
